RICHMOND TIMOTHY J.

Track

Insider profile

Performance

Overall performance
3.0
Performance over holding periods
3.0
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 46% 68% 82%
Transactions
29 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
RICHMOND TIMOTHY J.'s trades of Abbvie Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
160.47
Quantity 45,009 -38.0%
Value US$1,839,651
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
375.31
Quantity 84,668 +26.3%
Value US$2,827,934
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
171.28
Quantity 94,541 +19.2%
Value US$1,599,706
US Abbvie Inc (ABBV)
Transaction date
Proposed sale
Price
210.46
Quantity 21,250
Value US$4,472,184
US Abbvie Inc (ABBV)
Transaction date
Planned sale
Price
203.63
Quantity 4,829 -9.8%
Value US$983,329
US Abbvie Inc (ABBV)
Transaction date
Planned sale
Price
202.92
Quantity 13,073 -21.0%
Value US$2,652,773
US Abbvie Inc (ABBV)
Transaction date
Planned sale
Price
201.97
Quantity 4,308 -6.5%
Value US$870,087
US Abbvie Inc (ABBV)
Transaction date
Planned sale
Price
203.64
Quantity 1,526 -3.3%
Value US$310,755
US Abbvie Inc (ABBV)
Transaction date
Planned sale
Price
202.93
Quantity 4,781 -9.5%
Value US$970,208
US Abbvie Inc (ABBV)
Transaction date
Planned sale
Price
202.06
Quantity 1,400 -2.7%
Value US$282,884
US Abbvie Inc (ABBV)
Transaction date
Proposed sale
Price
202.90
Quantity 29,917
Value US$6,070,176
US Abbvie Inc (ABBV)
Transaction date
Planned sale
Price
177.71
Quantity 20,127 -59.3%
Value US$3,576,769
US Abbvie Inc (ABBV)
Transaction date
Planned sale
Price
176.35
Quantity 9,853 -22.5%
Value US$1,737,577
US Abbvie Inc (ABBV)
Transaction date
Planned sale
Price
177.71
Quantity 30,288 -40.9%
Value US$5,382,480
US Abbvie Inc (ABBV)
Transaction date
Planned sale
Price
176.40
Quantity 15,412 -17.2%
Value US$2,718,677
US Abbvie Inc (ABBV)
Transaction date
Proposed sale
Price
176.84
Quantity 75,680
Value US$13,383,591
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
153.62
Quantity 16,746 -54.8%
Value US$2,572,521
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
153.08
Quantity 27,395 -47.3%
Value US$4,193,583
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
164.10
Quantity 3,075 -18.2%
Value US$504,608
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
163.39
Quantity 39,295 -69.9%
Value US$6,420,410
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
149.09
Quantity 2,627 -16.0%
Value US$391,655
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
148.59
Quantity 14,424 -46.7%
Value US$2,143,196
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
147.52
Quantity 9,381 -23.3%
Value US$1,383,918
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
120.00
Quantity 50,350 -100.0%
Value US$6,042,000
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
108.59
Quantity 19,514 -100.0%
Value US$2,119,041
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
105.00
Quantity 51,990 -100.0%
Value US$5,458,950
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
85.00
Quantity 19,445 -100.0%
Value US$1,652,825
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
75.02
Quantity 15,515 -100.0%
Value US$1,163,873
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
118.67
Quantity 18,129 -50.8%
Value US$2,151,452
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
98.45
Quantity 87,040 -76.9%
Value US$8,569,053
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
65.29
Quantity 22,451 -46.3%
Value US$1,465,826
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
63.52
Quantity 21,583 -32.6%
Value US$1,370,952
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
55.00
Quantity 10,792 -14.0%
Value US$593,560
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
55.32
Quantity 2,074 -2.6%
Value US$114,738
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
60.30
Quantity 12,314 -10.3%
Value US$742,534
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
60.51
Quantity 2,074 -1.6%
Value US$125,492
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
58.70
Quantity 241 -0.2%
Value US$14,147
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
51.24
Quantity 200 -0.2%
Value US$10,247
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
51.23
Quantity 265 -0.3%
Value US$13,575
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
47.78
Quantity 560 -0.7%
Value US$26,757
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
47.78
Quantity 200 -0.2%
Value US$9,557
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
47.79
Quantity 700 -0.8%
Value US$33,450
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-04 2025-03-03
US Abbvie Inc (ABBV)
S Sale
45,009 -38.0%
160.47
US$1,839,651 		45,009 -38.0% 160.47 US$1,839,651
2025-03-04 2025-03-03
US Abbvie Inc (ABBV)
S Sale
84,668 +26.3%
375.31
US$2,827,934 		84,668 +26.3% 375.31 US$2,827,934
2025-03-04 2025-03-03
US Abbvie Inc (ABBV)
S Sale
94,541 +19.2%
171.28
US$1,599,706 		94,541 +19.2% 171.28 US$1,599,706
2025-03-03 2025-03-03
US Abbvie Inc (ABBV)
PrS Proposed sale
21,250
210.46
US$4,472,184 		21,250 210.46 US$4,472,184
2025-02-28 2025-02-26
US Abbvie Inc (ABBV)
PlS Planned sale
4,829 -9.8%
203.63
US$983,329 		4,829 -9.8% 203.63 US$983,329
2025-02-28 2025-02-26
US Abbvie Inc (ABBV)
PlS Planned sale
13,073 -21.0%
202.92
US$2,652,773 		13,073 -21.0% 202.92 US$2,652,773
2025-02-28 2025-02-26
US Abbvie Inc (ABBV)
PlS Planned sale
4,308 -6.5%
201.97
US$870,087 		4,308 -6.5% 201.97 US$870,087
2025-02-28 2025-02-26
US Abbvie Inc (ABBV)
PlS Planned sale
1,526 -3.3%
203.64
US$310,755 		1,526 -3.3% 203.64 US$310,755
2025-02-28 2025-02-26
US Abbvie Inc (ABBV)
PlS Planned sale
4,781 -9.5%
202.93
US$970,208 		4,781 -9.5% 202.93 US$970,208
2025-02-28 2025-02-26
US Abbvie Inc (ABBV)
PlS Planned sale
1,400 -2.7%
202.06
US$282,884 		1,400 -2.7% 202.06 US$282,884
2025-02-26 2025-02-26
US Abbvie Inc (ABBV)
PrS Proposed sale
29,917
202.90
US$6,070,176 		29,917 202.90 US$6,070,176
2024-03-05 2024-03-01
US Abbvie Inc (ABBV)
PlS Planned sale
20,127 -59.3%
177.71
US$3,576,769 		20,127 -59.3% 177.71 US$3,576,769
2024-03-05 2024-03-01
US Abbvie Inc (ABBV)
PlS Planned sale
9,853 -22.5%
176.35
US$1,737,577 		9,853 -22.5% 176.35 US$1,737,577
2024-03-05 2024-03-01
US Abbvie Inc (ABBV)
PlS Planned sale
30,288 -40.9%
177.71
US$5,382,480 		30,288 -40.9% 177.71 US$5,382,480
2024-03-05 2024-03-01
US Abbvie Inc (ABBV)
PlS Planned sale
15,412 -17.2%
176.40
US$2,718,677 		15,412 -17.2% 176.40 US$2,718,677
2024-03-01 2024-03-01
US Abbvie Inc (ABBV)
PrS Proposed sale
75,680
176.84
US$13,383,591 		75,680 176.84 US$13,383,591
2023-03-02 2023-03-01
US Abbvie Inc (ABBV)
S Sale
16,746 -54.8%
153.62
US$2,572,521 		16,746 -54.8% 153.62 US$2,572,521
2023-03-02 2023-03-01
US Abbvie Inc (ABBV)
S Sale
27,395 -47.3%
153.08
US$4,193,583 		27,395 -47.3% 153.08 US$4,193,583
2022-12-14 2022-12-12
US Abbvie Inc (ABBV)
S Sale
3,075 -18.2%
164.10
US$504,608 		3,075 -18.2% 164.10 US$504,608
2022-12-14 2022-12-12
US Abbvie Inc (ABBV)
S Sale
39,295 -69.9%
163.39
US$6,420,410 		39,295 -69.9% 163.39 US$6,420,410
2022-03-01 2022-03-01
US Abbvie Inc (ABBV)
S Sale
2,627 -16.0%
149.09
US$391,655 		2,627 -16.0% 149.09 US$391,655
2022-03-01 2022-03-01
US Abbvie Inc (ABBV)
S Sale
14,424 -46.7%
148.59
US$2,143,196 		14,424 -46.7% 148.59 US$2,143,196
2022-03-01 2022-03-01
US Abbvie Inc (ABBV)
S Sale
9,381 -23.3%
147.52
US$1,383,918 		9,381 -23.3% 147.52 US$1,383,918
2021-12-08 2021-12-06
US Abbvie Inc (ABBV)
S Sale
50,350 -100.0%
120.00
US$6,042,000 		50,350 -100.0% 120.00 US$6,042,000
2021-03-02 2021-03-01
US Abbvie Inc (ABBV)
S Sale
19,514 -100.0%
108.59
US$2,119,041 		19,514 -100.0% 108.59 US$2,119,041
2020-12-01 2020-11-27
US Abbvie Inc (ABBV)
S Sale
51,990 -100.0%
105.00
US$5,458,950 		51,990 -100.0% 105.00 US$5,458,950
2020-05-07 2020-05-05
US Abbvie Inc (ABBV)
S Sale
19,445 -100.0%
85.00
US$1,652,825 		19,445 -100.0% 85.00 US$1,652,825
2019-10-01 2019-09-27
US Abbvie Inc (ABBV)
S Sale
15,515 -100.0%
75.02
US$1,163,873 		15,515 -100.0% 75.02 US$1,163,873
2018-03-02 2018-02-28
US Abbvie Inc (ABBV)
S Sale
18,129 -50.8%
118.67
US$2,151,452 		18,129 -50.8% 118.67 US$2,151,452
2017-12-19 2017-12-18
US Abbvie Inc (ABBV)
S Sale
87,040 -76.9%
98.45
US$8,569,053 		87,040 -76.9% 98.45 US$8,569,053
2017-03-10 2017-03-10
US Abbvie Inc (ABBV)
S Sale
22,451 -46.3%
65.29
US$1,465,826 		22,451 -46.3% 65.29 US$1,465,826
2016-05-12 2016-05-10
US Abbvie Inc (ABBV)
S Sale
21,583 -32.6%
63.52
US$1,370,952 		21,583 -32.6% 63.52 US$1,370,952
2016-03-02 2016-03-01
US Abbvie Inc (ABBV)
S Sale
10,792 -14.0%
55.00
US$593,560 		10,792 -14.0% 55.00 US$593,560
2016-03-02 2016-02-29
US Abbvie Inc (ABBV)
S Sale
2,074 -2.6%
55.32
US$114,738 		2,074 -2.6% 55.32 US$114,738
2015-03-03 2015-03-02
US Abbvie Inc (ABBV)
S Sale
12,314 -10.3%
60.30
US$742,534 		12,314 -10.3% 60.30 US$742,534
2015-03-03 2015-02-27
US Abbvie Inc (ABBV)
S Sale
2,074 -1.6%
60.51
US$125,492 		2,074 -1.6% 60.51 US$125,492
2015-02-19 2015-02-17
US Abbvie Inc (ABBV)
S Sale
241 -0.2%
58.70
US$14,147 		241 -0.2% 58.70 US$14,147
2014-02-19 2014-02-18
US Abbvie Inc (ABBV)
S Sale
200 -0.2%
51.24
US$10,247 		200 -0.2% 51.24 US$10,247
2014-02-19 2014-02-18
US Abbvie Inc (ABBV)
S Sale
265 -0.3%
51.23
US$13,575 		265 -0.3% 51.23 US$13,575
2014-02-07 2014-02-05
US Abbvie Inc (ABBV)
S Sale
560 -0.7%
47.78
US$26,757 		560 -0.7% 47.78 US$26,757
2014-02-07 2014-02-05
US Abbvie Inc (ABBV)
S Sale
200 -0.2%
47.78
US$9,557 		200 -0.2% 47.78 US$9,557
2014-02-07 2014-02-05
US Abbvie Inc (ABBV)
S Sale
700 -0.8%
47.79
US$33,450 		700 -0.8% 47.79 US$33,450